Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy
May 31, 2024 08:36 ET
|
Ocugen
Established Medium Dose as Safe and Tolerable Dose in Current OCU410 Clinical TrialDSMB Recommends Continuing with High-Dose Cohort Dosing with Concurrent Phase 2 Dosing MALVERN, Pa., May 31, 2024 ...
Global Tetraspecific Antibodies Clinical Trials & Market Report 2024: Pioneering the Future of Cancer Treatment, Shift Towards Tetraspecific Antibodies Amidst Drug Resistance Challenges
May 31, 2024 04:48 ET
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Global Tetraspecific Antibodies Clinical Trials & Market Opportunity Insight 2024" report has been added to ResearchAndMarkets.com's...
Amyloidosis Global Clinical Trials Research 2024
May 30, 2024 07:17 ET
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Amyloidosis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The analyst's clinical trial...
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review 2024
May 30, 2024 07:10 ET
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The...
Global Mycosis Fungoides Clinical Trials Analysis Report 2024
May 30, 2024 04:17 ET
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Mycosis Fungoides - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offeringThe latest report offers a detailed...
Global Ferroptosis Targeting Therapy Clinical Trials Market 2024 - Clinical Trials Insight on 10+ Key Therapies in Trials
May 29, 2024 07:37 ET
|
Research and Markets
Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "Global Ferroptosis Targeting Therapy Market Opportunity & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering....
Comprehensive Review of Hospital Acquired Pneumonia (HAP) Clinical Trials 2024
May 28, 2024 09:38 ET
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Hospital Acquired Pneumonia (HAP) - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offering.The extensive...
Global Pulmonary Tuberculosis Clinical Trials Review 2024
May 28, 2024 09:26 ET
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Pulmonary Tuberculosis - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offering.A comprehensive report...
Global Juvenile Macular Degeneration Clinical Trials Review 2024, Featuring Lin Bioscience, Nanoscope Therapeutics, Alnylam Pharmaceuticals, Biophytis, Kubota Pharmaceutical and Nucleus Network
May 27, 2024 05:00 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Juvenile Macular Degeneration (Stargardt Disease) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...
Global Decompensated Cirrhosis Clinical Trials Review 2024, by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
May 27, 2024 04:44 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Decompensated Cirrhosis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...